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esponsProf. Zhonggao Gao is a Professor of the
Chinese Academy of Medical Sciences, Vice
President in the Department of Pharmaceutics,
Institute of Materia Medica. He received a Ph.
D. degree in Pharmacy in 1998, from Seoul
National University, Seoul, Republic of Korea,
and a Bachelor's degree in pharmacy in 1986,
from YanBian University, Yanji, China.
Prof. Gao is author or co-author of more
than 90 original research papers, 5 book
chapters and more than 20 patents. Cur-
s on functional material design and synthesisrently, Prof. Gao's studies focu
and preparation of nanocarriers for the targeting therapy. The major
research area is development of anticancer drug co-loaded siRNA
nanoparticles for targeting therapy, and ultrasound-mediated tumor ima-
ging and nanotherapy using drug loaded, block copolymer stabilized
perﬂuorocarbon nanoemulsions. His laboratory is also developing various
cell labeling and animal models for evaluation of the release of functional
carriers loading drug and gene from tumor blood vessel and therapeutically
efﬁciency in a dorsal skin-fold window chamber model.
Prof. Gao is member of numerous scientiﬁc societies, such as America
Association of Pharmaceutical Scientist and Controlled Release Society. He
was frequently invited to give presentations in international and national
conferences. He also services as Editorial Board Member of several journals,
such as Acta Pharmaceutica Sinica B and Chinese Medicinal Biotechnology.Zhonggao Gao
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Professor of Pharmacy, The Catholic Uni-
versity of Korea, Republic of Korea and an
Adjunct Research Associate Professor of
Pharmaceutics and Pharmaceutical Chem-
istry, The University of Utah, USA. He
received a Ph.D. in Pharmaceutics and
Pharmaceutical Chemistry from The Uni-
versity of Utah (Utah, USA) in 2007,
an MS degree in Materials Science and
Engineering from Gwangju Institute of
angju, Republic of Korea) in 1999, and aScience and Technology (Gw
Bachelor's degree in Industrial Chemistry from Hanyang University (Seoul,
Republic of Korea) in 1997.
Prof. Kang is author or co-author of more than 40 original research papers,
4 book chapters, 14 registered patents, and 7 pending patents. Currently, Prof.
Kang focuses on functional macromolecule-based nanomedicines and functional
nanosized delivery systems for subcellular targeting (e.g., nuclear targeting,
mitochondrial targeting, and cytosolic targeting) of chemical and biological
therapeutics. Recently, his interest is moving to drug re-routing (or re-targeting)
of action sites for maximizing therapeutic effects and minimizing side effects.
Prof. Kang is an active member of numerous scientiﬁc societies including in
Controlled Release Society, The Pharmaceutical Society of Korea, The Polymer
Society of Korea, The Biomaterials Society, of Korea, The Korean Society of
Pharmaceutical Sciences and Technology, The Korean Chemical Society, and
The Biotherapeutics Delivery Society. He also serves an Associate Editor of
Journal of Korean Chemical Society, an Editorial Board Member of Acta
Pharmaceutica Sinica B, a Reviewer of several prestige journals, including in
Journal of Controlled Release, International Journal of Pharmaceutics,
Molecular Pharmaceutics, Advanced Materials, Smalls, etc.E-mail address: hckang@catholic.ac.kr
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